SunOpta Announces First Quarter 2022 Financial Results
SunOpta reported first-quarter 2022 revenue of $240.2 million, a 15.7% increase from the previous year, driven by 13.4% growth in plant-based foods and 18.7% in fruit-based foods. Gross profit reached $28.0 million, but gross margin decreased to 11.7% due to inflationary pressures. Adjusted EBITDA was $15.6 million, down 14.7% year-over-year. Despite challenges, the company is on track with major capacity expansion projects and reaffirms its 2022 revenue outlook of $890 million to $930 million. Net earnings were $0.7 million, down from $1.7 million in the prior year.
- Revenue growth of 15.7% year-over-year.
- Strong sequential revenue growth of 17.6%.
- Gross profit growth of 52.1% from Q4 2021.
- Adjusted EBITDA increased 46% from Q4 2021.
- On track with significant capacity expansion projects.
- Gross margin decreased by 270 basis points to 11.7%.
- Net earnings declined to $0.7 million from $1.7 million year-over-year.
- Adjusted EBITDA down 14.7% compared to Q1 2021.
Revenue growth of
Sequential revenue growth of
Strong quarterly year over year revenue, gross profit and EBITDA growth expected for the balance of the year
Major capacity expansion projects on track
All amounts are expressed in
First quarter 2022 highlights:
-
Revenues of
for the first quarter of 2022 increased$240.2 million 15.7% reflecting13.4% growth in plant-based and18.7% increase in fruit-based compared to the prior year -
Gross margin decreased 270 basis points to
11.7% from14.4% in the prior year, primarily reflecting inflationary factors impacting raw materials, freight, labor and utilities. Gross margin increased 270 basis points to11.7% from9.0% in the fourth quarter of 2021, reflecting increased production and pricing actions. -
Net earnings from continuing operations were
compared to$0.7 million in the prior year.$1.7 million -
Adjusted earnings¹ attributable to common shareholders was
or$0.6 million per diluted common share in the first quarter of 2022, compared to earnings of$0.01 or$1.3 million per diluted common share in the first quarter of 2021.$0.01 -
Adjusted EBITDA¹ of
, or$15.6 million 6.5% of revenues for the first quarter of 2022, was down14.7% versus or$18.3 million 8.8% of revenues in the first quarter of 2021. Adjusted EBITDA increased46% versus in the fourth quarter of 2021.$10.7 million
“We delivered strong first quarter results compared to Q4, reflecting significant progress on recent initiatives to enhance capacity and productivity coupled with robust demand across our portfolio. Plant-based revenue increased
First Quarter 2022 Results
Revenues of
Gross profit was
Segment operating income¹ was
Adjusted EBITDA¹ was
Earnings attributable to common shareholders for the first quarter of 2022 was
Adjusted earnings¹ in the first quarter of 2022 was
Please refer to the discussion and table below under “Non-GAAP Measures”.
Balance Sheet and Cash Flow
As of
2022 Outlook2
We are reaffirming our previously provided outlook for fiscal 2022, including:
Consolidated revenue range:
Consolidated adjusted EBITDA1 range:
Conference Call
¹ See discussion of non-GAAP measures
2 The Company has included certain forward-looking statements about the future financial performance that include non-GAAP financial measures, including Adjusted EBITDA. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts that are excluded from these non-GAAP financial measures is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because management cannot reliably predict all of the necessary components of such GAAP measures. Historically, management has excluded the following items from certain of these non-GAAP measures, and such items may also be excluded in future periods and could be significant amounts.
- Expenses related to the acquisition or divestiture of a business, including business development costs, impairment of assets, integration costs, severance, retention costs and transaction costs;
- Start-up costs of new facilities and equipment;
- Charges associated with restructuring and cost saving initiatives, including but not limited to asset impairments, accelerated depreciation, severance costs and lease abandonment charges;
- Asset impairment charges and facility closure costs;
- Legal settlements or awards; and
- The tax effect of the above items.
About
Forward-Looking Statements
Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our expectation for quarterly year over year revenue, gross profit and EBITDA growth, our belief that we have remedied production challenges in our plants, our expectation that the
|
|||||||
Consolidated Statements of Operations |
|||||||
For the quarters ended |
|||||||
(Unaudited) |
|||||||
(All dollar amounts expressed in thousands of |
|||||||
|
|
|
|
|
|
||
|
|
|
|
Quarter ended |
|||
|
|
|
|
|
|
||
|
|
|
|
$ |
$ |
||
|
|
|
|
|
|
||
Revenues |
240,173 |
|
207,640 |
|
|||
|
|
|
|
|
|
||
Cost of goods sold |
212,182 |
|
177,651 |
|
|||
|
|
|
|
|
|
||
Gross profit |
27,991 |
|
29,989 |
|
|||
|
|
|
|
|
|
||
Selling, general and administrative expenses |
21,935 |
|
20,874 |
|
|||
Intangible asset amortization |
2,612 |
|
2,194 |
|
|||
Other expense, net |
287 |
|
1,615 |
|
|||
Foreign exchange loss (gain) |
(472 |
) |
836 |
|
|||
|
|
|
|
|
|
||
Earnings from continuing operations before the following |
3,629 |
|
4,470 |
|
|||
|
|
|
|
|
|
||
Interest expense, net |
2,530 |
|
1,660 |
|
|||
|
|
|
|
|
|
||
Earnings from continuing operations before income taxes |
1,099 |
|
2,810 |
|
|||
|
|
|
|
|
|
||
Income tax expense |
445 |
|
1,138 |
|
|||
|
|
|
|
|
|
||
Earnings from continuing operations |
654 |
|
1,672 |
|
|||
Earnings from discontinued operations |
3,566 |
|
- |
|
|||
Net earnings |
4,220 |
|
1,672 |
|
|||
|
|
|
|
|
|
||
Dividends and accretion on preferred stock |
(755 |
) |
(1,953 |
) |
|||
|
|
|
|
|
|
||
Earnings (loss) attributable to common shareholders |
3,465 |
|
(281 |
) |
|||
|
|
|
|
|
|
||
Basic and diluted earnings (loss) per share |
|
|
|||||
|
From continuing operations |
(0.00 |
) |
(0.00 |
) |
||
|
From discontinued operations |
0.03 |
|
- |
|
||
Basic and diluted earnings (loss) per share |
0.03 |
|
(0.00 |
) |
|||
|
|
|
|
|
|
||
Weighted-average common shares outstanding (000s) |
|
|
|||||
|
Basic |
107,399 |
|
96,120 |
|
||
|
Diluted |
107,399 |
|
96,120 |
|
|
|||||||
Consolidated Balance Sheets |
|||||||
As at |
|||||||
(Unaudited) |
|||||||
(All dollar amounts expressed in thousands of |
|||||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
$ |
$ |
||
|
|
|
|
|
|
||
ASSETS |
|
|
|||||
Current assets |
|
|
|||||
|
Cash and cash equivalents |
495 |
|
227 |
|
||
|
Accounts receivable |
98,220 |
|
84,702 |
|
||
|
Inventories |
217,975 |
|
220,143 |
|
||
|
Prepaid expenses and other current assets |
16,040 |
|
16,638 |
|
||
|
Income taxes recoverable |
8,130 |
|
8,259 |
|
||
Total current assets |
340,860 |
|
329,969 |
|
|||
|
|
|
|
|
|
||
Property, plant and equipment, net |
245,898 |
|
219,537 |
|
|||
Operating lease right-of-use assets |
43,174 |
|
47,245 |
|
|||
Intangible assets, net |
145,828 |
|
148,440 |
|
|||
|
3,998 |
|
3,998 |
|
|||
Other assets |
6,057 |
|
5,930 |
|
|||
|
|
|
|
|
|
||
Total assets |
785,815 |
|
755,119 |
|
|||
|
|
|
|
|
|
||
LIABILITIES |
|
|
|||||
Current liabilities |
|
|
|||||
|
Accounts payable and accrued liabilities |
135,518 |
|
121,430 |
|
||
|
Current portion of long-term debt |
17,864 |
|
9,760 |
|
||
|
Current portion of operating lease liabilities |
10,104 |
|
12,203 |
|
||
Total current liabilities |
163,486 |
|
143,393 |
|
|||
|
|
|
|
|
|
||
Long-term debt |
231,822 |
|
214,843 |
|
|||
Operating lease liabilities |
37,185 |
|
39,028 |
|
|||
Long-term liabilities |
4,034 |
|
2,241 |
|
|||
Deferred income taxes |
10,758 |
|
22,485 |
|
|||
Total liabilities |
447,285 |
|
421,990 |
|
|||
|
|
|
|
|
|
||
Series B-1 preferred stock |
28,291 |
|
28,145 |
|
|||
|
|
|
|
|
|
||
SHAREHOLDERS' EQUITY |
|
|
|||||
Common shares |
437,451 |
|
436,463 |
|
|||
Additional paid-in capital |
24,042 |
|
23,240 |
|
|||
Accumulated deficit |
(152,617 |
) |
(156,082 |
) |
|||
Accumulated other comprehensive income |
1,363 |
|
1,363 |
|
|||
Total shareholders' equity |
310,239 |
|
304,984 |
|
|||
|
|
|
|
|
|
||
Total liabilities and shareholders' equity |
785,815 |
|
755,119 |
|
|
|||||||
Consolidated Statements of Cash Flows |
|||||||
For the quarters ended |
|||||||
(Unaudited) |
|||||||
(Expressed in thousands of |
|||||||
|
|
|
|
|
|
||
|
|
|
|
Quarter ended |
|||
|
|
|
|
|
|
||
|
|
|
|
$ |
$ |
||
|
|
|
|
|
|
||
CASH PROVIDED BY (USED IN) |
|
|
|||||
Operating activities |
|
|
|||||
Net earnings |
4,220 |
|
1,672 |
|
|||
Earnings from discontinued operations |
3,566 |
|
- |
|
|||
Earnings from continuing operations |
654 |
|
1,672 |
|
|||
Items not affecting cash: |
|
|
|||||
|
Depreciation and amortization |
9,413 |
|
8,043 |
|
||
|
Amortization of debt issuance costs |
375 |
|
285 |
|
||
|
Deferred income taxes |
80 |
|
837 |
|
||
|
Stock-based compensation |
1,629 |
|
3,973 |
|
||
|
Other |
111 |
|
(169 |
) |
||
|
Changes in operating assets and liabilities |
3,281 |
|
(21,656 |
) |
||
Net cash provided by (used in) operating activities of continuing operations |
15,543 |
|
(7,015 |
) |
|||
|
|
|
|
|
|
||
Investing activities |
|
|
|||||
Additions to property, plant and equipment |
(25,722 |
) |
(9,297 |
) |
|||
Proceeds from sale of assets |
1,204 |
|
1,350 |
|
|||
Net cash used in investing activities of continuing operations |
(24,518 |
) |
(7,947 |
) |
|||
Net cash used in investing activities of discontinued operations |
- |
|
(13,380 |
) |
|||
Net cash used in investing activities |
(24,518 |
) |
(21,327 |
) |
|||
|
|
|
|
|
|
||
Financing activities |
|
|
|||||
Increase (decrease) under revolving credit facilities |
(10,305 |
) |
41,585 |
|
|||
Borrowings of long-term debt |
22,897 |
|
486 |
|
|||
Repayment of long-term debt |
(2,395 |
) |
(4,085 |
) |
|||
Payment of debt issuance costs |
(506 |
) |
(1,828 |
) |
|||
Proceeds from the exercise of stock options and employee share purchases |
250 |
|
2,640 |
|
|||
Payment of withholding taxes on stock-based awards |
(89 |
) |
(6,071 |
) |
|||
Payment of cash dividends on preferred stock |
(609 |
) |
(3,420 |
) |
|||
Payment of share issuance costs |
- |
|
(262 |
) |
|||
Net cash provided by financing activities of continuing operations |
9,243 |
|
29,045 |
|
|||
Net cash used in financing activities of discontinued operations |
- |
|
(200 |
) |
|||
Net cash provided by financing activities |
9,243 |
|
28,845 |
|
|||
|
|
|
|
|
|
||
Increase in cash and cash equivalents in the period |
268 |
|
503 |
|
|||
Cash and cash equivalent, beginning of the period |
227 |
|
251 |
|
|||
Cash and cash equivalents, end of the period |
495 |
|
754 |
|
|
|||||||
Segmented Information |
|||||||
For the quarters ended |
|||||||
Unaudited |
|||||||
(Expressed in thousands of |
|||||||
|
|
|
|
|
|
||
|
|
|
|
Quarter ended |
|||
|
|
|
|
|
|
||
|
|
|
|
$ |
$ |
||
Segment revenues from external customers: |
|
|
|||||
|
|
135,511 |
|
119,451 |
|
||
|
|
104,662 |
|
88,189 |
|
||
|
|
Total segment revenues from external customers |
240,173 |
|
207,640 |
|
|
|
|
|
|
||||
Segment gross profit: |
|
|
|||||
|
|
19,980 |
|
23,158 |
|
||
|
|
8,011 |
|
6,831 |
|
||
|
|
Total segment gross profit |
27,991 |
|
29,989 |
|
|
|
|
|
|
|
|
||
Segment operating income (loss): |
|
|
|||||
|
|
8,096 |
|
13,317 |
|
||
|
|
784 |
|
(1,894 |
) |
||
|
Corporate Services |
(4,964 |
) |
(5,338 |
) |
||
|
|
Total segment operating income |
3,916 |
|
6,085 |
|
|
|
|
|
|
|
|
||
Segment gross profit percentage: |
|
|
|||||
|
|
14.7 |
% |
19.4 |
% |
||
|
|
7.7 |
% |
7.7 |
% |
||
|
|
Total segment gross profit percentage |
11.7 |
% |
14.4 |
% |
|
|
|
|
|
|
|
||
Segment operating income (loss) percentage: |
|
|
|||||
|
|
6.0 |
% |
11.1 |
% |
||
|
|
0.7 |
% |
-2.1 |
% |
||
|
|
Total segment operating income percentage |
1.6 |
% |
2.9 |
% |
Non-GAAP Measures
In addition to reporting financial results in accordance with
In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These items are identified in the tables below. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for, an analysis of the Company’s results as reported under
Adjusted Earnings
When assessing its financial performance, the Company uses an internal measure that excludes charges and gains that it believes are not reflective of normal operations. This information is provided to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Adjusted earnings and adjusted earnings per diluted share should not be considered in isolation or as a substitute for performance measures calculated in accordance with
The following is a tabular presentation of adjusted earnings and adjusted earnings per diluted share, including a reconciliation from earnings from continuing operations, which the Company believes to be the most directly comparable
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
Per Share |
|
|
Per Share |
||||
|
For the quarter ended |
$ |
$ |
|
$ |
$ |
|||||||
|
Earnings from continuing operations |
654 |
|
|
|
1,672 |
|
|
|||||
|
Dividends and accretion on preferred stock |
(755 |
) |
|
|
(1,953 |
) |
|
|||||
|
Loss attributable to common shareholders |
(101 |
) |
(0.00 |
) |
|
(281 |
) |
(0.00 |
) |
|||
|
Adjusted for: |
|
|
|
|
|
|||||||
|
|
Start-up costs(a) |
440 |
|
|
|
- |
|
|
||||
|
|
Business development costs(b) |
183 |
|
|
|
169 |
|
|
||||
|
|
Restructuring costs(c) |
- |
|
|
|
1,432 |
|
|
||||
|
|
Other(d) |
287 |
|
|
|
183 |
|
|
||||
|
|
Net income tax effect(e) |
(239 |
) |
|
|
(240 |
) |
|
||||
|
Adjusted earnings |
570 |
|
0.01 |
|
|
1,263 |
|
0.01 |
|
(a) |
|
Represents incremental direct costs incurred in connection with plant expansion projects and new product introductions before the project or product reaches normal production levels, including costs for the hiring and training of additional personnel, fees for outside services, travel costs, and plant- and production-related expenses. For the first quarter of 2022, start-up costs mainly related to new employee hires for our plant-based beverage facility under construction in |
(b) |
|
Represents third-party costs associated with business development activities, including costs related to the evaluation, execution, and integration of external acquisitions and divestitures, internal expansion projects, and other strategic initiatives, which were recorded in SG&A expenses. |
(c) |
|
For the first quarter of 2021, represents costs to complete the exit from our |
(d) |
|
For the first quarter of 2022, other includes asset impairment charges. For the first quarter of 2021, other reflects professional fees incurred in connection with post-closing matters related to the 2020 divestiture of our global ingredients business, Tradin Organic. |
(e) |
|
Reflects the tax effect of the preceding adjustments to earnings calculated based on the statutory tax rates applicable in the tax jurisdiction of the underlying adjustment. |
Segment Operating Income and Adjusted EBITDA
The Company defines segment operating income as earnings from continuing operations before income taxes, interest expense and other income/expense items, and adjusted EBITDA as segment operating income plus depreciation, amortization, stock-based compensation, and other unusual items that affect the comparability of operating performance as identified above in the determination of adjusted earnings. The following is a tabular presentation of segment operating income and adjusted EBITDA, including a reconciliation to earnings from continuing operations, which the Company believes to be the most directly comparable
|
|
|
|
|
|
|
|
|
For the quarter ended |
$ |
|
$ |
|||
|
Earnings from continuing operations |
654 |
|
1,672 |
|||
|
Income tax expense |
445 |
|
1,138 |
|||
|
Interest expense, net |
2,530 |
|
1,660 |
|||
|
Other expense, net |
287 |
|
1,615 |
|||
|
Total segment operating income |
3,916 |
|
6,085 |
|||
|
|
Depreciation and amortization |
9,413 |
|
8,043 |
||
|
|
Stock-based compensation |
1,629 |
|
3,973 |
||
|
|
Start-up costs(a) |
440 |
|
- |
||
|
|
Business development costs(b) |
183 |
|
169 |
||
|
Adjusted EBITDA |
15,581 |
|
18,270 |
(a) |
|
For the first quarter of 2022, start-up costs mainly related to new employee hires for our plant-based beverage facility under construction in |
(b) |
|
For the first quarters of 2022 and 2021, business development activities were related to the exploration of potential strategic opportunities, which costs were recorded in SG&A expenses. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005281/en/
ICR
646-277-1260
reed.anderson@icrinc.com
Source:
FAQ
What were SunOpta's Q1 2022 revenue figures and growth percentage?
How did SunOpta's gross profit change in Q1 2022?
What is the adjusted EBITDA for SunOpta in Q1 2022?
What is SunOpta's revenue outlook for 2022?